인바디

041830KOSDAQ

53.3 / 100

Reference Date: 2026-09-08

Financial Score19.0 / 40

News Sentiment17.3 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Plunged 15.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

InBody is a global medical equipment manufacturer established in 1996, specializing in body composition analyzers, automatic blood pressure monitors, and home-use body composition analyzers. With 83% of sales generated overseas, the company achieved a 14.4% revenue increase to 233.9 billion won in 2025.

Number of Employees

370people

Average Salary

52.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

24.76Industry Average 15.001.5Point

1.7x industry avg (risky)

PBR

2.53Industry Average 1.200.0Point

2.1x industry avg (risky)

ROE

10.10Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

2.62Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.2% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼2.1% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 12.8% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 3Neutral 2Negative 0Average Sentiment Score 69

Positive
인바디 "비만약 근손실 관리 공략"
인바디의 차기철 회장이 빅파마와 중국 약국 시장 진출을 통해 비만치료제의 효과적인 근손실 관리 전략을 강화하고 있어 긍정적인 시장 전망을 제시했습니다.
Positive
‘30살’ 인바디, 시니어 건강관리 솔루션 강화 [서울바이오헬스대상.....
InBody celebrates 30th anniversary with advanced senior health solutions focusing on fall risk assessment.
Neutral
[글로벌 바이오워치]美 IPO 시장 다시 활활…상장사수 확대
Global IPO market surge positively impacts broader biotech sector but lacks direct impact on 인바디.

Detailed Momentum

52-week position6.0Point

52w upper range (75%)

Current 60,000Won52-week high 70,80052-week low 26,550

1-month return0.0Point

1m -15.25% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral반기보고서 (2026.06)2026-08-14
Neutral자기주식처분결과보고서2026-08-14
Neutral주식등의대량보유상황보고서(약식)2026-08-12